## Abstract Protein–protein interactions represent a highly populated class of targets for drug discovery. However, such systems present a number of unique challenges. This review presents an analysis of individual protein‐protein interaction systems which have recently yielded success in discoveri
✦ LIBER ✦
A fully integrated protein crystallization platform for small-molecule drug discovery
✍ Scribed by David Hosfield; John Palan; Mark Hilgers; Daniel Scheibe; Duncan E. McRee; Raymond C. Stevens
- Book ID
- 117704545
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 502 KB
- Volume
- 142
- Category
- Article
- ISSN
- 1047-8477
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Protein–protein interactions as targets
✍
David C. Fry
📂
Article
📅
2006
🏛
Wiley (John Wiley & Sons)
🌐
English
⚖ 713 KB
Bromodomains: a new target class for sma
✍
Chun-wa Chung; David F. Tough
📂
Article
📅
2012
🏛
Elsevier Science
🌐
English
⚖ 989 KB
X-ray crystallography: assessment and va
✍
Cooper, David R; Porebski, Przemyslaw J; Chruszcz, Maksymilian; Minor, Wladek
📂
Article
📅
2011
🏛
Informa plc
🌐
English
⚖ 714 KB
[Methods and Principles in Medicinal Che
✍
Jahnke, Wolfgang; Erlanson, Daniel A.
📂
Article
📅
2006
🏛
Wiley
⚖ 327 KB
👁 1 views
drug discovery" [6-8, 11, 12] has a number of other advantages over conventional screening, including a more efficient sampling of chemical space and a higher hitrate due to lower molecular complexity [13]. Both of these factors mean that the number of compounds screened can be considerably reduced.
BioCores: identification of a drug/natur
✍
Roman Kombarov; Andrea Altieri; Dmitry Genis; Mikhail Kirpichenok; Valeriy Kochu
📂
Article
📅
2009
🏛
Springer
🌐
English
⚖ 724 KB
[RSC Drug Discovery] Physico-Chemical an
✍
Luque, Javier; Barril, Xavier
📂
Article
📅
2012
🏛
Royal Society of Chemistry
⚖ 751 KB